Ayaka Okamoto
Papers
2
Total Citations
2
H-Index
1
About
Dr. Ayaka Okamoto is a leading urologic surgeon and researcher whose work centers on advancing surgical outcomes for patients with bladder cancer, particularly through robot-assisted techniques. Her primary research areas include minimally invasive radical cystectomy, intracorporeal urinary diversion, and neoadjuvant chemotherapy protocols. Dr. Okamoto’s major contributions lie in refining complex robotic procedures, such as robot-assisted radical cystectomy with intracorporeal ileal neobladder reconstruction, demonstrating that these technically demanding surgeries can be performed safely with favorable perioperative outcomes. She has also pioneered the study of split-dose cisplatin-based neoadjuvant chemotherapy, offering a strategy to preserve renal function in muscle-invasive bladder cancer patients who might otherwise be ineligible for standard cisplatin regimens. Her work, though early in its citation impact, addresses critical gaps in surgical oncology and chemotherapeutic tolerability. Dr. Okamoto’s research is particularly notable for its focus on translating complex surgical innovations into practical, patient-centered improvements in cancer care, making her a rising authority in the field of robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2